- Home
- ABVC vs INMB Comparison
ABVC vs INMB Comparison
Compare ABVC & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABVC | INMB |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.6M | 37.2M |
| IPO Year | 2009 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ABVC | INMB |
|---|---|---|
| Price | $1.36 | $1.38 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.40 |
| AVG Volume (30 Days) | 115.0K | ★ 467.6K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.14 | ★ 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $509,589.00 | $50,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $0.88 | $1.09 |
| 52 Week High | $4.02 | $11.64 |
Technical Indicators
Market Signals| Indicator | ABVC | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 62.00 | 46.98 |
| Support Level | $0.96 | $1.37 |
| Resistance Level | $1.46 | $1.48 |
| Average True Range (ATR) | 0.13 | 0.09 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 79.52 | 18.67 |
Price Performance
Historical ComparisonAbout ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.